type: timeline_event
On March 18, 2020, as COVID-19 infections surged across the United States and hospitals faced dire shortages of personal protective equipment, ventilators, and testing supplies, President Donald Trump signed an executive order invoking the Defense Production Act of 1950. However, the invocation was largely symbolic. Trump immediately told reporters he viewed the authority as a "break the glass" measure and hoped he would not need to use it, effectively refusing to compel private manufacturers to produce desperately needed medical supplies. Behind the scenes, the U.S. Chamber of Commerce and major corporate lobbying groups had mounted an aggressive campaign against mandatory production orders, warning the White House that compelling private industry amounted to "nationalization" and would set a dangerous precedent for government intervention in the private sector.
The lobbying effort found a receptive audience in Jared Kushner, who was leading a parallel and chaotic supply chain effort from the White House. Kushner's team favored voluntary partnerships with corporations over mandatory orders, an approach that allowed companies to negotiate favorable terms, pricing, and liability protections before agreeing to produce supplies. Meanwhile, Peter Navarro, designated as the DPA policy coordinator, pushed for more aggressive use of the act but was repeatedly overruled. The result was a critical window of inaction during the most dangerous phase of the pandemic's first wave, as hospitals resorted to reusing single-use masks, fashioning gowns from garbage bags, and pleading with the public for donations of protective equipment.
The decision to invoke but not enforce the DPA represented a textbook case of corporate capture during a national emergency. The Chamber of Commerce's framing of mandatory production orders as government overreach prevailed over the public health imperative, effectively allowing corporations to dictate the terms of their own participation in pandemic response. States and hospitals were left to compete against each other and against the federal government on the open market, driving prices for N95 masks up by as much as 1,000 percent. The pattern established in March 2020 would define the federal pandemic response for months: performative invocations of emergency authority coupled with a systematic refusal to use that authority in ways that might inconvenience powerful corporate interests.